Insights
News | Bloomberg Business
Secret Rebates Erode Drugmaker Revenue, Industry Study Says
Robert Langreth
January 18, 2017
Aaron Vandervelde comments on branded drug companies’ share of total US spending on their products and other topics discussed in the paper The Pharmaceutical Supply Chain: Gross Drug Expenditures Realized by Stakeholders, which he coauthored with Eleanor Blalock.